Marka R. Crittenden

6.6k total citations
106 papers, 4.0k citations indexed

About

Marka R. Crittenden is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marka R. Crittenden has authored 106 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Oncology, 69 papers in Immunology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marka R. Crittenden's work include Cancer Immunotherapy and Biomarkers (63 papers), Immunotherapy and Immune Responses (42 papers) and CAR-T cell therapy research (23 papers). Marka R. Crittenden is often cited by papers focused on Cancer Immunotherapy and Biomarkers (63 papers), Immunotherapy and Immune Responses (42 papers) and CAR-T cell therapy research (23 papers). Marka R. Crittenden collaborates with scholars based in United States, United Kingdom and Spain. Marka R. Crittenden's co-authors include Michael J. Gough, Kristina H. Young, Jason R. Baird, Benjamin Cottam, Shelly Bambina, David J. Friedman, Brendan D. Curti, Pippa Newell, Walter J. Urba and Richard G. Vile and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Marka R. Crittenden

103 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marka R. Crittenden United States	37	2.8k	2.4k	719	583	323	106	4.0k
Christopher R. Heery United States	32	2.5k 0.9×	1.7k 0.7×	876 1.2×	854 1.5×	292 0.9×	112	3.8k
Ainhoa Arina United States	28	2.3k 0.8×	2.7k 1.2×	1.1k 1.5×	486 0.8×	288 0.9×	50	4.2k
Andrew J. Long United States	8	2.9k 1.0×	2.8k 1.2×	688 1.0×	481 0.8×	195 0.6×	11	4.6k
William L. Redmond United States	28	1.9k 0.7×	2.3k 1.0×	593 0.8×	508 0.9×	186 0.6×	79	3.3k
Ryan Emerson United States	32	2.2k 0.8×	2.6k 1.1×	1.0k 1.4×	462 0.8×	368 1.1×	64	4.5k
Eric R. Lutz United States	15	2.6k 0.9×	2.3k 0.9×	673 0.9×	298 0.5×	177 0.5×	37	3.5k
Michael Bowman United States	8	2.7k 1.0×	2.8k 1.2×	785 1.1×	487 0.8×	173 0.5×	13	4.4k
Diego Chowell United States	16	2.2k 0.8×	1.4k 0.6×	877 1.2×	790 1.4×	267 0.8×	37	3.3k
Mala Chakraborty United States	21	2.1k 0.8×	2.0k 0.8×	564 0.8×	499 0.9×	462 1.4×	33	3.1k
Joseph F. Grosso United States	25	4.4k 1.6×	3.7k 1.5×	821 1.1×	811 1.4×	197 0.6×	39	6.4k

Countries citing papers authored by Marka R. Crittenden

Since Specialization

Citations

This map shows the geographic impact of Marka R. Crittenden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marka R. Crittenden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marka R. Crittenden more than expected).

Fields of papers citing papers by Marka R. Crittenden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marka R. Crittenden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marka R. Crittenden. The network helps show where Marka R. Crittenden may publish in the future.

Co-authorship network of co-authors of Marka R. Crittenden

This figure shows the co-authorship network connecting the top 25 collaborators of Marka R. Crittenden. A scholar is included among the top collaborators of Marka R. Crittenden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marka R. Crittenden. Marka R. Crittenden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kramer, Gwen, Tiffany C. Blair, Shelly Bambina, et al.. (2024). Fluorescence tracking demonstrates T cell recirculation is transiently impaired by radiation therapy to the tumor. Scientific Reports. 14(1). 11909–11909. 6 indexed citations

Baird, Jason R., Alejandro Alice, Ryoichi Saito, et al.. (2024). A novel small molecule Enpp1 inhibitor improves tumor control following radiation therapy by targeting stromal Enpp1 expression. Scientific Reports. 14(1). 29913–29913. 1 indexed citations

Jagodinsky, Justin C., Won Jong Jin, Paul A. Clark, et al.. (2024). Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade. Science Translational Medicine. 16(765). eadk0642–eadk0642. 22 indexed citations

Blair, Tiffany C., Shelly Bambina, Gwen Kramer, et al.. (2022). Fluorescent tracking identifies key migratory dendritic cells in the lymph node after radiotherapy. Life Science Alliance. 5(9). e202101337–e202101337. 22 indexed citations

Leidner, Rom S., Marka R. Crittenden, Kristina H. Young, et al.. (2021). Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 9(5). e002485–e002485. 120 indexed citations

Demaria, Sandra, Chandan Guha, Jonathan D. Schoenfeld, et al.. (2021). Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?. Journal for ImmunoTherapy of Cancer. 9(4). e002038–e002038. 170 indexed citations

Tormoen, Garth W., Tiffany C. Blair, Shelly Bambina, et al.. (2020). Targeting MerTK Enhances Adaptive Immune Responses After Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 108(1). 93–103. 23 indexed citations

Blair, Tiffany C., Shelly Bambina, Alejandro Alice, et al.. (2020). Dendritic Cell Maturation Defines Immunological Responsiveness of Tumors to Radiation Therapy. The Journal of Immunology. 204(12). 3416–3424. 48 indexed citations

Papadopoulos, Kyriakos P., Melissa L. Johnson, A. Craig Lockhart, et al.. (2019). First-In-Human Study of Cemiplimab Alone or In Combination with Radiotherapy and/or Low-dose Cyclophosphamide in Patients with Advanced Malignancies. Clinical Cancer Research. 26(5). 1025–1033. 50 indexed citations

10.

Bambina, Shelly, Alejandro Alice, Kyra D. Zens, et al.. (2019). A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity. PLoS ONE. 14(1). e0209153–e0209153. 19 indexed citations

11.

Baird, Jason R., R. Bryan Bell, Victoria Troesch, et al.. (2018). Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma. Cancer Research. 78(21). 6308–6319. 54 indexed citations

12.

Baird, Jason R., David J. Friedman, Benjamin Cottam, et al.. (2015). Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors. Cancer Research. 76(1). 50–61. 201 indexed citations

13.

Sckisel, Gail D., Myriam N. Bouchlaka, Arta M. Monjazeb, et al.. (2015). Out-of-Sequence Signal 3 Paralyzes Primary CD4+ T-Cell-Dependent Immunity. Immunity. 43(2). 240–250. 88 indexed citations

14.

Young, Kristina H., Pippa Newell, Benjamin Cottam, et al.. (2014). TGFβ Inhibition Prior to Hypofractionated Radiation Enhances Efficacy in Preclinical Models. Cancer Immunology Research. 2(10). 1011–1022. 47 indexed citations

15.

Crittenden, Marka R., Holbrook E. Kohrt, Ronald Levy, et al.. (2014). Current Clinical Trials Testing Combinations of Immunotherapy and Radiation. Seminars in Radiation Oncology. 25(1). 54–64. 114 indexed citations

16.

Gough, Michael J., Kristina H. Young, & Marka R. Crittenden. (2013). The Impact of the Myeloid Response to Radiation Therapy. SHILAP Revista de lepidopterología. 2013. 1–14. 47 indexed citations

17.

Gough, Michael J., Marka R. Crittenden, Uma Thanarajasingam, et al.. (2005). Gene Therapy to Manipulate Effector T Cell Trafficking to Tumors for Immunotherapy. The Journal of Immunology. 174(9). 5766–5773. 51 indexed citations

18.

Bonnotte, Bernard, Marka R. Crittenden, Nicolas Larmonier, Michael J. Gough, & Richard G. Vile. (2004). MIP-3α Transfection into a Rodent Tumor Cell Line Increases Intratumoral Dendritic Cell Infiltration but Enhances (Facilitates) Tumor Growth and Decreases Immunogenicity. The Journal of Immunology. 173(8). 4929–4935. 46 indexed citations

19.

Kramer, Joel H., et al.. (1992). A Prospective Study of Cognitive Functioning Following Low-Dose Cranial Radiation for Bone Marrow Transplantation. PEDIATRICS. 90(3). 447–450. 33 indexed citations

20.

Gordon, Tavia, Marka R. Crittenden, & William Haenszel. (1961). End results and mortality trends in cancer. II. Cancer mortality trends in the United States, 1930-1955.. PubMed. 6. 133–350. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact